DAWN DIAZ: Open Payments
NPI 1366827925 · YULEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 61 payments from 21 companies in 2025. Trend: 2023 $2,030 · 2024 $1,616 · 2025 $1,265
Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $191 |
| Abbott Laboratories | 8 | $185 |
| Amgen Inc. | 9 | $167 |
| ABBVIE INC. | 4 | $103 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| PFIZER INC. | 4 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Novo Nordisk Inc | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Lilly USA, LLC | 2 | $35 |
Products named: JARDIANCE, FREESTYLE LIBRE 3, REPATHA, OTEZLA, LEQVIO, Kerendia, PREVNAR 20, SHINGRIX.
Industry payments across FL — which companies pay providers there.
